Empower Clinics and Fobi Launch Premier SMS Integration System

3 years ago

Developed to Streamline Kai Labs COVID-19 Testing, the Program Will be Rolled Out Across Empower's Subsidiaries to Optimize the Patient…

LifeSpeak Inc. Acquires Leading US SaaS Platform Provider Torchlight to Address Global Demand for Digital-First Elder and Child Care Education and Support Resources

3 years ago

Mental Health and Total Wellbeing Education Leader Continues to Diversify and Deepen Capabilities with Acquisition of Boston-Based Provider of On-Demand…

Champions Oncology Reports Record Quarterly Revenue of $11.8 Million

3 years ago

Reported income from operations of $263,000HACKENSACK, NJ / ACCESSWIRE / December 13, 2021 / Champions Oncology, Inc. (NASDAQ:CSBR), a leading…

Dr. Kayte’s Formulas: A First-of-Its-Kind Product to Support the Health of Women with Breast Implants

3 years ago

LOS ANGELES, CA / ACCESSWIRE / December 13, 2021 / The number of women in the United States alone who…

Open Mind Health Says Purpose is the Key to Post-COVID Workplace Culture

3 years ago

The Great Resignation Shows American Workers Need Better Mental Health AccessSAN DIEGO, CA / ACCESSWIRE / December 13, 2021 /…

Rpharmy Launches Rhazdrugs Platform for Hazardous Drug Handling, Disposal Safety Information at Point of Care

3 years ago

Leading Formulary Management, Drug Safety Information Provider Improves Healthcare Worker Safety by Providing Vital Safety Guidance In EHR, On Any…

European Medicines Agency Grants Orphan Drug Designation for Crofelemer to Napo EU, Jaguar Health’s Italian Subsidiary, for Short Bowel Syndrome

3 years ago

The recognition of Orphan Drug Designation in Europe for crofelemer for this rare disease is the first key milestone of…

Empower Clinics Kai Medical Laboratory Secures COVID-19 Testing Contract For Large Gaming Event In Las Vegas

3 years ago

Kai Medical Laboratory to Provide Over 6,000 Rapid Antigen and PCR COVID-19 TestsVANCOUVER, BC / ACCESSWIRE / December 13, 2021…

Aytu BioPharma Announces FDA Clearance of Investigational New Drug (IND) Application for AR101/Enzastaurin in Vascular Ehlers-Danlos Syndrome

3 years ago

Pivotal clinical trial will begin in first half of 2022ENGLEWOOD, CO / ACCESSWIRE / December 13, 2021 / Aytu BioPharma,…

Halberd Successfully Eradicates Interleukin-1 in Its Continued Progress Toward Eliminating Neurodegenerative Diseases

3 years ago

JACKSON CENTER, PA / ACCESSWIRE / December 13, 2021 / Halberd Corporation (OTC PINK:HALB) has demonstrated 100% eradication of Interleukin-1…